Blog

Federal judge denies Invokana plaintiffs’ bid to keep cases in state court

Feb. 23, 2017 – San Diego, CA — Dozens of plaintiffs hoping to move their Invokana lawsuits back to state court in Pennsylvania were dealt...



J&J continues settlement trend, resolves another Risperdal lawsuit one week before its trial

Feb. 22, 2017 – San Diego, CA − One week before a Risperdal gynecomastia trial was set to begin in Philadelphia, Janssen Pharmaceuticals settled the case...



Brazil stops sale of Essure pointing to numerous side effects

Feb. 21, 2017 — San Diego, CA — In a move that is sure to spark hope among the thousands of Essure Advocates here...



MDL Panel widens scope of Taxotere litigation, concludes generic drug complaints are allowed

Feb. 20, 2017 – San Diego, CA —Taxotere hair loss lawsuits are steadily being filed in Louisiana federal court following a massive spike during the...



Both parties agree to push back Xarelto bellwether trials again

Feb. 17, 2017 – San Diego, CA — Plaintiffs in the four lawsuits picked to be tried first in the Xarelto multidistrict litigation (MDL) will...



First Ethicon Physiomesh lawsuit to head to trial scheduled for 2018

Feb. 16, 2017 – San Diego, CA — Johnson & Johnson’s Ethicon Inc. will defend itself in the first Physiomesh lawsuit to go to trial...



Hernia Mesh Complications: How to Submit Adverse Event Reports and Why You Should

Feb. 15, 2017 – San Diego, CA — Hernia mesh complications can occur long after the initial hernia repair surgery. This point was highlighted...



Government report on power morcellators highlights failures of FDA adverse event reporting

Feb. 14, 2017 – San Diego, CA — A new report from the Government Accountability Office (GAO) delves deep into the risks posed by power...



DuPont agrees to $671 million settlement with plaintiffs injured by cancer-causing Teflon chemical

Feb. 13, 2017 – San Diego, CA — DuPont has agreed to pay more than $670 million in cash to settle thousands of lawsuits accusing...



Xarelto maker stops latest trial early citing positive results

Feb. 10, 2017 – San Diego, CA — The results of the newest Xarelto clinical trial were so promising, Janssen Research & Development decided to...